Global Medical Human Erythropoietin Injection Supply, Demand and Key Producers, 2023-2029

Page: 128

Published Date: 18 Nov 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Medical Human Erythropoietin Injection market size is expected to reach $ 14120 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

Medical Human Erythropoietin Injection is a crucial drug for treating anemia, and its market position continues to strengthen. With the increasing awareness of health and the growing number of patients with chronic diseases, the demand for Medical Human Erythropoietin Injection is on the rise. The market size is gradually expanding, and sales are continuously increasing. Its specific uses include areas such as renal anemia and anemia post-leukemia chemotherapy, making it widely applied in clinical medicine. The future development prospects are promising, as advancements in medical technology and the growing needs of patients will contribute to the increasingly vital role of Medical Human Erythropoietin Injection in treating various anemia symptoms, providing more effective medical choices for patients.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

This report studies the global Medical Human Erythropoietin Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Medical Human Erythropoietin Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Medical Human Erythropoietin Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Medical Human Erythropoietin Injection total production and demand, 2018-2029, (K Units)
Global Medical Human Erythropoietin Injection total production value, 2018-2029, (USD Million)
Global Medical Human Erythropoietin Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Human Erythropoietin Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Medical Human Erythropoietin Injection domestic production, consumption, key domestic manufacturers and share
Global Medical Human Erythropoietin Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Medical Human Erythropoietin Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Medical Human Erythropoietin Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Medical Human Erythropoietin Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson, Roche, Kyowa Kirin, LG Chem, Daewoong Pharmaceutical, Wockhardt, CJ Healthcare and 3SBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Medical Human Erythropoietin Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Medical Human Erythropoietin Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Medical Human Erythropoietin Injection Market, Segmentation by Type
    Epoetin-alfa
    Epoetin-beta
    Darbepoetin-alfa
    Others

Global Medical Human Erythropoietin Injection Market, Segmentation by Application
    Anemia
    Kidney Disorders
    Others

Companies Profiled:
    Amgen
    Johnson & Johnson
    Roche
    Kyowa Kirin
    LG Chem
    Daewoong Pharmaceutical
    Wockhardt
    CJ Healthcare
    3SBio
    Kexing Biopharm
    Harbin Pharmaceutical Group
    Beijing Four Rings Bio-Pharmaceutical

Key Questions Answered
1. How big is the global Medical Human Erythropoietin Injection market?
2. What is the demand of the global Medical Human Erythropoietin Injection market?
3. What is the year over year growth of the global Medical Human Erythropoietin Injection market?
4. What is the production and production value of the global Medical Human Erythropoietin Injection market?
5. Who are the key producers in the global Medical Human Erythropoietin Injection market?

Table of Contents

1 Supply Summary
    1.1 Medical Human Erythropoietin Injection Introduction
    1.2 World Medical Human Erythropoietin Injection Supply & Forecast
        1.2.1 World Medical Human Erythropoietin Injection Production Value (2018 & 2022 & 2029)
        1.2.2 World Medical Human Erythropoietin Injection Production (2018-2029)
        1.2.3 World Medical Human Erythropoietin Injection Pricing Trends (2018-2029)
    1.3 World Medical Human Erythropoietin Injection Production by Region (Based on Production Site)
        1.3.1 World Medical Human Erythropoietin Injection Production Value by Region (2018-2029)
        1.3.2 World Medical Human Erythropoietin Injection Production by Region (2018-2029)
        1.3.3 World Medical Human Erythropoietin Injection Average Price by Region (2018-2029)
        1.3.4 North America Medical Human Erythropoietin Injection Production (2018-2029)
        1.3.5 Europe Medical Human Erythropoietin Injection Production (2018-2029)
        1.3.6 China Medical Human Erythropoietin Injection Production (2018-2029)
        1.3.7 Japan Medical Human Erythropoietin Injection Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Medical Human Erythropoietin Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Medical Human Erythropoietin Injection Major Market Trends

2 Demand Summary
    2.1 World Medical Human Erythropoietin Injection Demand (2018-2029)
    2.2 World Medical Human Erythropoietin Injection Consumption by Region
        2.2.1 World Medical Human Erythropoietin Injection Consumption by Region (2018-2023)
        2.2.2 World Medical Human Erythropoietin Injection Consumption Forecast by Region (2024-2029)
    2.3 United States Medical Human Erythropoietin Injection Consumption (2018-2029)
    2.4 China Medical Human Erythropoietin Injection Consumption (2018-2029)
    2.5 Europe Medical Human Erythropoietin Injection Consumption (2018-2029)
    2.6 Japan Medical Human Erythropoietin Injection Consumption (2018-2029)
    2.7 South Korea Medical Human Erythropoietin Injection Consumption (2018-2029)
    2.8 ASEAN Medical Human Erythropoietin Injection Consumption (2018-2029)
    2.9 India Medical Human Erythropoietin Injection Consumption (2018-2029)

3 World Medical Human Erythropoietin Injection Manufacturers Competitive Analysis
    3.1 World Medical Human Erythropoietin Injection Production Value by Manufacturer (2018-2023)
    3.2 World Medical Human Erythropoietin Injection Production by Manufacturer (2018-2023)
    3.3 World Medical Human Erythropoietin Injection Average Price by Manufacturer (2018-2023)
    3.4 Medical Human Erythropoietin Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Medical Human Erythropoietin Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Medical Human Erythropoietin Injection in 2022
        3.5.3 Global Concentration Ratios (CR8) for Medical Human Erythropoietin Injection in 2022
    3.6 Medical Human Erythropoietin Injection Market: Overall Company Footprint Analysis
        3.6.1 Medical Human Erythropoietin Injection Market: Region Footprint
        3.6.2 Medical Human Erythropoietin Injection Market: Company Product Type Footprint
        3.6.3 Medical Human Erythropoietin Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Medical Human Erythropoietin Injection Production Value Comparison
        4.1.1 United States VS China: Medical Human Erythropoietin Injection Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Medical Human Erythropoietin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Medical Human Erythropoietin Injection Production Comparison
        4.2.1 United States VS China: Medical Human Erythropoietin Injection Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Medical Human Erythropoietin Injection Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Medical Human Erythropoietin Injection Consumption Comparison
        4.3.1 United States VS China: Medical Human Erythropoietin Injection Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Medical Human Erythropoietin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Medical Human Erythropoietin Injection Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Medical Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Medical Human Erythropoietin Injection Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Medical Human Erythropoietin Injection Production (2018-2023)
    4.5 China Based Medical Human Erythropoietin Injection Manufacturers and Market Share
        4.5.1 China Based Medical Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Medical Human Erythropoietin Injection Production Value (2018-2023)
        4.5.3 China Based Manufacturers Medical Human Erythropoietin Injection Production (2018-2023)
    4.6 Rest of World Based Medical Human Erythropoietin Injection Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Medical Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production (2018-2023)

5 Market Analysis by Type
    5.1 World Medical Human Erythropoietin Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Epoetin-alfa
        5.2.2 Epoetin-beta
        5.2.3 Darbepoetin-alfa
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Medical Human Erythropoietin Injection Production by Type (2018-2029)
        5.3.2 World Medical Human Erythropoietin Injection Production Value by Type (2018-2029)
        5.3.3 World Medical Human Erythropoietin Injection Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Medical Human Erythropoietin Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Anemia
        6.2.2 Kidney Disorders
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Medical Human Erythropoietin Injection Production by Application (2018-2029)
        6.3.2 World Medical Human Erythropoietin Injection Production Value by Application (2018-2029)
        6.3.3 World Medical Human Erythropoietin Injection Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Medical Human Erythropoietin Injection Product and Services
        7.1.4 Amgen Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 Johnson & Johnson
        7.2.1 Johnson & Johnson Details
        7.2.2 Johnson & Johnson Major Business
        7.2.3 Johnson & Johnson Medical Human Erythropoietin Injection Product and Services
        7.2.4 Johnson & Johnson Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Johnson & Johnson Recent Developments/Updates
        7.2.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.3 Roche
        7.3.1 Roche Details
        7.3.2 Roche Major Business
        7.3.3 Roche Medical Human Erythropoietin Injection Product and Services
        7.3.4 Roche Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Roche Recent Developments/Updates
        7.3.6 Roche Competitive Strengths & Weaknesses
    7.4 Kyowa Kirin
        7.4.1 Kyowa Kirin Details
        7.4.2 Kyowa Kirin Major Business
        7.4.3 Kyowa Kirin Medical Human Erythropoietin Injection Product and Services
        7.4.4 Kyowa Kirin Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kyowa Kirin Recent Developments/Updates
        7.4.6 Kyowa Kirin Competitive Strengths & Weaknesses
    7.5 LG Chem
        7.5.1 LG Chem Details
        7.5.2 LG Chem Major Business
        7.5.3 LG Chem Medical Human Erythropoietin Injection Product and Services
        7.5.4 LG Chem Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 LG Chem Recent Developments/Updates
        7.5.6 LG Chem Competitive Strengths & Weaknesses
    7.6 Daewoong Pharmaceutical
        7.6.1 Daewoong Pharmaceutical Details
        7.6.2 Daewoong Pharmaceutical Major Business
        7.6.3 Daewoong Pharmaceutical Medical Human Erythropoietin Injection Product and Services
        7.6.4 Daewoong Pharmaceutical Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Daewoong Pharmaceutical Recent Developments/Updates
        7.6.6 Daewoong Pharmaceutical Competitive Strengths & Weaknesses
    7.7 Wockhardt
        7.7.1 Wockhardt Details
        7.7.2 Wockhardt Major Business
        7.7.3 Wockhardt Medical Human Erythropoietin Injection Product and Services
        7.7.4 Wockhardt Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Wockhardt Recent Developments/Updates
        7.7.6 Wockhardt Competitive Strengths & Weaknesses
    7.8 CJ Healthcare
        7.8.1 CJ Healthcare Details
        7.8.2 CJ Healthcare Major Business
        7.8.3 CJ Healthcare Medical Human Erythropoietin Injection Product and Services
        7.8.4 CJ Healthcare Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CJ Healthcare Recent Developments/Updates
        7.8.6 CJ Healthcare Competitive Strengths & Weaknesses
    7.9 3SBio
        7.9.1 3SBio Details
        7.9.2 3SBio Major Business
        7.9.3 3SBio Medical Human Erythropoietin Injection Product and Services
        7.9.4 3SBio Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 3SBio Recent Developments/Updates
        7.9.6 3SBio Competitive Strengths & Weaknesses
    7.10 Kexing Biopharm
        7.10.1 Kexing Biopharm Details
        7.10.2 Kexing Biopharm Major Business
        7.10.3 Kexing Biopharm Medical Human Erythropoietin Injection Product and Services
        7.10.4 Kexing Biopharm Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Kexing Biopharm Recent Developments/Updates
        7.10.6 Kexing Biopharm Competitive Strengths & Weaknesses
    7.11 Harbin Pharmaceutical Group
        7.11.1 Harbin Pharmaceutical Group Details
        7.11.2 Harbin Pharmaceutical Group Major Business
        7.11.3 Harbin Pharmaceutical Group Medical Human Erythropoietin Injection Product and Services
        7.11.4 Harbin Pharmaceutical Group Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
        7.11.6 Harbin Pharmaceutical Group Competitive Strengths & Weaknesses
    7.12 Beijing Four Rings Bio-Pharmaceutical
        7.12.1 Beijing Four Rings Bio-Pharmaceutical Details
        7.12.2 Beijing Four Rings Bio-Pharmaceutical Major Business
        7.12.3 Beijing Four Rings Bio-Pharmaceutical Medical Human Erythropoietin Injection Product and Services
        7.12.4 Beijing Four Rings Bio-Pharmaceutical Medical Human Erythropoietin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Beijing Four Rings Bio-Pharmaceutical Recent Developments/Updates
        7.12.6 Beijing Four Rings Bio-Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Medical Human Erythropoietin Injection Industry Chain
    8.2 Medical Human Erythropoietin Injection Upstream Analysis
        8.2.1 Medical Human Erythropoietin Injection Core Raw Materials
        8.2.2 Main Manufacturers of Medical Human Erythropoietin Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Medical Human Erythropoietin Injection Production Mode
    8.6 Medical Human Erythropoietin Injection Procurement Model
    8.7 Medical Human Erythropoietin Injection Industry Sales Model and Sales Channels
        8.7.1 Medical Human Erythropoietin Injection Sales Model
        8.7.2 Medical Human Erythropoietin Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Medical Human Erythropoietin Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Medical Human Erythropoietin Injection Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Medical Human Erythropoietin Injection Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Medical Human Erythropoietin Injection Production Value Market Share by Region (2018-2023)
    Table 5. World Medical Human Erythropoietin Injection Production Value Market Share by Region (2024-2029)
    Table 6. World Medical Human Erythropoietin Injection Production by Region (2018-2023) & (K Units)
    Table 7. World Medical Human Erythropoietin Injection Production by Region (2024-2029) & (K Units)
    Table 8. World Medical Human Erythropoietin Injection Production Market Share by Region (2018-2023)
    Table 9. World Medical Human Erythropoietin Injection Production Market Share by Region (2024-2029)
    Table 10. World Medical Human Erythropoietin Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Medical Human Erythropoietin Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Medical Human Erythropoietin Injection Major Market Trends
    Table 13. World Medical Human Erythropoietin Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Medical Human Erythropoietin Injection Consumption by Region (2018-2023) & (K Units)
    Table 15. World Medical Human Erythropoietin Injection Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Medical Human Erythropoietin Injection Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Medical Human Erythropoietin Injection Producers in 2022
    Table 18. World Medical Human Erythropoietin Injection Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Medical Human Erythropoietin Injection Producers in 2022
    Table 20. World Medical Human Erythropoietin Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Medical Human Erythropoietin Injection Company Evaluation Quadrant
    Table 22. World Medical Human Erythropoietin Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Medical Human Erythropoietin Injection Production Site of Key Manufacturer
    Table 24. Medical Human Erythropoietin Injection Market: Company Product Type Footprint
    Table 25. Medical Human Erythropoietin Injection Market: Company Product Application Footprint
    Table 26. Medical Human Erythropoietin Injection Competitive Factors
    Table 27. Medical Human Erythropoietin Injection New Entrant and Capacity Expansion Plans
    Table 28. Medical Human Erythropoietin Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Medical Human Erythropoietin Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Medical Human Erythropoietin Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Medical Human Erythropoietin Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Medical Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Medical Human Erythropoietin Injection Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Medical Human Erythropoietin Injection Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Medical Human Erythropoietin Injection Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Medical Human Erythropoietin Injection Production Market Share (2018-2023)
    Table 37. China Based Medical Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Medical Human Erythropoietin Injection Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Medical Human Erythropoietin Injection Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Medical Human Erythropoietin Injection Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Medical Human Erythropoietin Injection Production Market Share (2018-2023)
    Table 42. Rest of World Based Medical Human Erythropoietin Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production Market Share (2018-2023)
    Table 47. World Medical Human Erythropoietin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Medical Human Erythropoietin Injection Production by Type (2018-2023) & (K Units)
    Table 49. World Medical Human Erythropoietin Injection Production by Type (2024-2029) & (K Units)
    Table 50. World Medical Human Erythropoietin Injection Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Medical Human Erythropoietin Injection Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Medical Human Erythropoietin Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Medical Human Erythropoietin Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Medical Human Erythropoietin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Medical Human Erythropoietin Injection Production by Application (2018-2023) & (K Units)
    Table 56. World Medical Human Erythropoietin Injection Production by Application (2024-2029) & (K Units)
    Table 57. World Medical Human Erythropoietin Injection Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Medical Human Erythropoietin Injection Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Medical Human Erythropoietin Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Medical Human Erythropoietin Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Amgen Basic Information, Manufacturing Base and Competitors
    Table 62. Amgen Major Business
    Table 63. Amgen Medical Human Erythropoietin Injection Product and Services
    Table 64. Amgen Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Amgen Recent Developments/Updates
    Table 66. Amgen Competitive Strengths & Weaknesses
    Table 67. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 68. Johnson & Johnson Major Business
    Table 69. Johnson & Johnson Medical Human Erythropoietin Injection Product and Services
    Table 70. Johnson & Johnson Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Johnson & Johnson Recent Developments/Updates
    Table 72. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 73. Roche Basic Information, Manufacturing Base and Competitors
    Table 74. Roche Major Business
    Table 75. Roche Medical Human Erythropoietin Injection Product and Services
    Table 76. Roche Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Roche Recent Developments/Updates
    Table 78. Roche Competitive Strengths & Weaknesses
    Table 79. Kyowa Kirin Basic Information, Manufacturing Base and Competitors
    Table 80. Kyowa Kirin Major Business
    Table 81. Kyowa Kirin Medical Human Erythropoietin Injection Product and Services
    Table 82. Kyowa Kirin Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kyowa Kirin Recent Developments/Updates
    Table 84. Kyowa Kirin Competitive Strengths & Weaknesses
    Table 85. LG Chem Basic Information, Manufacturing Base and Competitors
    Table 86. LG Chem Major Business
    Table 87. LG Chem Medical Human Erythropoietin Injection Product and Services
    Table 88. LG Chem Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. LG Chem Recent Developments/Updates
    Table 90. LG Chem Competitive Strengths & Weaknesses
    Table 91. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 92. Daewoong Pharmaceutical Major Business
    Table 93. Daewoong Pharmaceutical Medical Human Erythropoietin Injection Product and Services
    Table 94. Daewoong Pharmaceutical Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Daewoong Pharmaceutical Recent Developments/Updates
    Table 96. Daewoong Pharmaceutical Competitive Strengths & Weaknesses
    Table 97. Wockhardt Basic Information, Manufacturing Base and Competitors
    Table 98. Wockhardt Major Business
    Table 99. Wockhardt Medical Human Erythropoietin Injection Product and Services
    Table 100. Wockhardt Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Wockhardt Recent Developments/Updates
    Table 102. Wockhardt Competitive Strengths & Weaknesses
    Table 103. CJ Healthcare Basic Information, Manufacturing Base and Competitors
    Table 104. CJ Healthcare Major Business
    Table 105. CJ Healthcare Medical Human Erythropoietin Injection Product and Services
    Table 106. CJ Healthcare Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. CJ Healthcare Recent Developments/Updates
    Table 108. CJ Healthcare Competitive Strengths & Weaknesses
    Table 109. 3SBio Basic Information, Manufacturing Base and Competitors
    Table 110. 3SBio Major Business
    Table 111. 3SBio Medical Human Erythropoietin Injection Product and Services
    Table 112. 3SBio Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. 3SBio Recent Developments/Updates
    Table 114. 3SBio Competitive Strengths & Weaknesses
    Table 115. Kexing Biopharm Basic Information, Manufacturing Base and Competitors
    Table 116. Kexing Biopharm Major Business
    Table 117. Kexing Biopharm Medical Human Erythropoietin Injection Product and Services
    Table 118. Kexing Biopharm Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Kexing Biopharm Recent Developments/Updates
    Table 120. Kexing Biopharm Competitive Strengths & Weaknesses
    Table 121. Harbin Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 122. Harbin Pharmaceutical Group Major Business
    Table 123. Harbin Pharmaceutical Group Medical Human Erythropoietin Injection Product and Services
    Table 124. Harbin Pharmaceutical Group Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Harbin Pharmaceutical Group Recent Developments/Updates
    Table 126. Beijing Four Rings Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 127. Beijing Four Rings Bio-Pharmaceutical Major Business
    Table 128. Beijing Four Rings Bio-Pharmaceutical Medical Human Erythropoietin Injection Product and Services
    Table 129. Beijing Four Rings Bio-Pharmaceutical Medical Human Erythropoietin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Medical Human Erythropoietin Injection Upstream (Raw Materials)
    Table 131. Medical Human Erythropoietin Injection Typical Customers
    Table 132. Medical Human Erythropoietin Injection Typical Distributors
List of Figure
    Figure 1. Medical Human Erythropoietin Injection Picture
    Figure 2. World Medical Human Erythropoietin Injection Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Medical Human Erythropoietin Injection Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Medical Human Erythropoietin Injection Production (2018-2029) & (K Units)
    Figure 5. World Medical Human Erythropoietin Injection Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Medical Human Erythropoietin Injection Production Value Market Share by Region (2018-2029)
    Figure 7. World Medical Human Erythropoietin Injection Production Market Share by Region (2018-2029)
    Figure 8. North America Medical Human Erythropoietin Injection Production (2018-2029) & (K Units)
    Figure 9. Europe Medical Human Erythropoietin Injection Production (2018-2029) & (K Units)
    Figure 10. China Medical Human Erythropoietin Injection Production (2018-2029) & (K Units)
    Figure 11. Japan Medical Human Erythropoietin Injection Production (2018-2029) & (K Units)
    Figure 12. Medical Human Erythropoietin Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 15. World Medical Human Erythropoietin Injection Consumption Market Share by Region (2018-2029)
    Figure 16. United States Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 17. China Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 18. Europe Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 19. Japan Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 22. India Medical Human Erythropoietin Injection Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Medical Human Erythropoietin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Medical Human Erythropoietin Injection Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Medical Human Erythropoietin Injection Markets in 2022
    Figure 26. United States VS China: Medical Human Erythropoietin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Medical Human Erythropoietin Injection Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Medical Human Erythropoietin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Medical Human Erythropoietin Injection Production Market Share 2022
    Figure 30. China Based Manufacturers Medical Human Erythropoietin Injection Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Medical Human Erythropoietin Injection Production Market Share 2022
    Figure 32. World Medical Human Erythropoietin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Medical Human Erythropoietin Injection Production Value Market Share by Type in 2022
    Figure 34. Epoetin-alfa
    Figure 35. Epoetin-beta
    Figure 36. Darbepoetin-alfa
    Figure 37. Others
    Figure 38. World Medical Human Erythropoietin Injection Production Market Share by Type (2018-2029)
    Figure 39. World Medical Human Erythropoietin Injection Production Value Market Share by Type (2018-2029)
    Figure 40. World Medical Human Erythropoietin Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 41. World Medical Human Erythropoietin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 42. World Medical Human Erythropoietin Injection Production Value Market Share by Application in 2022
    Figure 43. Anemia
    Figure 44. Kidney Disorders
    Figure 45. Others
    Figure 46. World Medical Human Erythropoietin Injection Production Market Share by Application (2018-2029)
    Figure 47. World Medical Human Erythropoietin Injection Production Value Market Share by Application (2018-2029)
    Figure 48. World Medical Human Erythropoietin Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 49. Medical Human Erythropoietin Injection Industry Chain
    Figure 50. Medical Human Erythropoietin Injection Procurement Model
    Figure 51. Medical Human Erythropoietin Injection Sales Model
    Figure 52. Medical Human Erythropoietin Injection Sales Channels, Direct Sales, and Distribution
    Figure 53. Methodology
    Figure 54. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical

Related Reports

Global Medical Human Erythropoietin Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Medical Human Erythropoietin Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Nov 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Human Erythropoietin Injection market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.

Global Medical Human Erythropoietin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Human Erythropoietin Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medical Human Erythropoietin Injection market size was valued at USD 9433.4 million in 2023 and is forecast to a readjusted size of USD 14120 million by 2030 with a CAGR of 5.9% during review period.

Product Tags

Medical Human Erythropoietin Injection

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>